Literature DB >> 27699624

Time to Progression of Pancreatic Cancer: Evaluation with Multi-Detector Computed Tomography.

Su Joa Ahn1, Seung Joon Choi2, Hyung Sik Kim3.   

Abstract

PURPOSE: The aim of this study is to evaluate the natural history of untreated pancreatic cancer, with a particular emphasis on the growth rate of primary tumor and development of metastatic disease.
METHODS: One hundred patients with histologically proven pancreatic ductal adenocarcinoma examined with at least two CT scans with no intervening treatment were included. Tumor diameters and volumes were measured in CT scans and tumor growth rates and volume doubling times (VDTs) were calculated. The relationship between initial tumor size, growth rate, and distant metastasis development were investigated.
RESULTS: Included tumors were 1.0-6.2 cm (mean, 2.9 ± 1.3 cm) in diameter and 5.5-1225.9 cm3 (mean, 120.6 ± 158.9 cm3) in volume at the initial CT. Tumor growth rates were -0.4 to 19.9 cm/year (mean, 4.2 ± 3.8 cm/year) in diameter, and 11.1-13,321.5 cm3/year (mean, 727.8 ± 1609.5 cm3/year) in volume corresponding to VDT of 20.0-976.8 days (mean, 132.3 ± 132.1 days). The growth rate was significantly associated with the initial diameter and volume (p < 0.001). The development of distant metastasis was significantly associated with initial diameter (p < 0.05), volume (p = 0.015), and volume growth rate (p = 0.002).
CONCLUSIONS: The growth rate and VDTs of untreated pancreatic cancers varied widely, from less than a month to more than 4 years, positively associated with tumor size. The small tumors tend to grow slowly and have low risk for developing metastasis.

Entities:  

Keywords:  Computed tomography; Growth rate; Pancreatic ductal adenocarcinoma

Mesh:

Year:  2017        PMID: 27699624     DOI: 10.1007/s12029-016-9876-7

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  24 in total

1.  Clinical value of manual fusion of PET and CT images in patients with suspected recurrent colorectal cancer.

Authors:  Yuji Nakamoto; Setsu Sakamoto; Tomohisa Okada; Michio Senda; Tatsuya Higashi; Tsuneo Saga; Kaori Togashi
Journal:  AJR Am J Roentgenol       Date:  2007-01       Impact factor: 3.959

Review 2.  Spectrum of (18)F-FDG PET/CT appearances in peritoneal disease.

Authors:  Marina-Portia Anthony; Pek-Lan Khong; Jingbo Zhang
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

3.  Imaging of early pancreatic cancer on multidetector row helical computed tomography.

Authors:  K Takeshita; K Kutomi; T Haruyama; A Watanabe; S Furui; J Fukushima; T Asano
Journal:  Br J Radiol       Date:  2010-05-04       Impact factor: 3.039

4.  Small carcinoma of the pancreas is curable: new computed tomography finding, pathological study and postoperative results from a single institute.

Authors:  Yasuhiro Shimizu; Kenzo Yasui; Kiyoshi Matsueda; Akio Yanagisawa; Kenji Yamao
Journal:  J Gastroenterol Hepatol       Date:  2005-10       Impact factor: 4.029

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

6.  Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT.

Authors:  Yoko Satoh; Tomoaki Ichikawa; Utarou Motosugi; Kazufumi Kimura; Hironobu Sou; Katsuhiro Sano; Tsutomu Araki
Journal:  AJR Am J Roentgenol       Date:  2011-02       Impact factor: 3.959

7.  Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.

Authors:  Laura Evangelista; Annalori Panunzio; Roberta Polverosi; Fabio Pomerri; Domenico Rubello
Journal:  AJR Am J Roentgenol       Date:  2014-03       Impact factor: 3.959

8.  Spectrum of MRI appearances of untreated metastases of the liver.

Authors:  Ioana-Maria Danet; Richard C Semelka; Polytimi Leonardou; Larissa Braga; Georgeta Vaidean; John T Woosley; Masayuki Kanematsu
Journal:  AJR Am J Roentgenol       Date:  2003-09       Impact factor: 3.959

Review 9.  Pancreatic cancer.

Authors:  Donghui Li; Keping Xie; Robert Wolff; James L Abbruzzese
Journal:  Lancet       Date:  2004-03-27       Impact factor: 79.321

10.  Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database.

Authors:  Karl Y Bilimoria; David J Bentrem; Clifford Y Ko; Jamie Ritchey; Andrew K Stewart; David P Winchester; Mark S Talamonti
Journal:  Cancer       Date:  2007-08-15       Impact factor: 6.860

View more
  4 in total

1.  Acute Pancreatitis as the Initial Presentation of Pancreatic Adenocarcinoma does not Impact Short- and Long-term Outcomes of Curative Intent Surgery: A Study of the French Surgical Association.

Authors:  Renato Micelli Lupinacci; Matthieu Faron; Philippe Bachellier; Alain Sauvanet; Alain Beauchet; Yves-Patrice Le Treut; Mustapha Adham; Jean-Yves Mabrut; Jean-Robert Delpero; François Paye
Journal:  World J Surg       Date:  2021-06-30       Impact factor: 3.352

2.  Pancreatic Duct Stricture That Rapidly Progressed to Pancreatic Ductal Adenocarcinoma and Formed a Mass within 3 Months: A Case Report.

Authors:  Shin Kato; Kenji Chinen; Susumu Shinoura; Fumihito Kunishima
Journal:  Case Rep Gastroenterol       Date:  2018-06-05

3.  Retrospective evaluation of venous phase contrast-enhanced computed tomography images in patients who developed pancreatic adenocarcinomas after treatment for nonpancreatic primary cancer.

Authors:  Ryo Takaji; Yasunari Yamada; Ryuichi Shimada; Shunro Matsumoto; Tsutomu Daa; Yuichi Endo; Masafumi Inomata; Yoshiki Asayama
Journal:  BJR Open       Date:  2021-07-05

4.  Identification of distinct slow mode of reversible adaptation of pancreatic ductal adenocarcinoma to the prolonged acidic pH microenvironment.

Authors:  Tzu-Chin Wu; Chien-Yu Liao; Wei-Chien Lu; Chuang-Rung Chang; Fang-Yu Tsai; Shih-Sheng Jiang; Tsung-Hsien Chen; Kurt Ming-Chao Lin; Li-Tzong Chen; Wun-Shaing Wayne Chang
Journal:  J Exp Clin Cancer Res       Date:  2022-04-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.